Benign Pancreatic Hyperenzinemia - Gullo's Syndrome

Authors

  • Víctor Raúl Luraschi Centurión Ministerio de Salud Pública y Bienestar Social, Hospital General de Luque, Cirugía General.Luque, Paraguay. https://orcid.org/0009-0001-3512-5888 (unauthenticated)
  • Rita Monthzerrat Miranda Vergara Ministerio de Salud Pública y Bienestar Social, Hospital General de Luque, Cirugía General.Luque, Paraguay.
  • Oscar Arturo Pizurno Marmol Ministerio de Salud Pública y Bienestar Social, Hospital General de Luque, Cirugía General.Luque, Paraguay.
  • Roun Kim Ministerio de Salud Pública y Bienestar Social, Hospital General de Luque, Cirugía General.Luque, Paraguay. https://orcid.org/0009-0004-3502-3912 (unauthenticated)

DOI:

https://doi.org/10.69940/sld.20240807

Keywords:

Pancreatitis, Benign pancreatitis, Hyperenzynemia, Gullo´s syndrome, Pancreatic Enzymes, Pancreatic Disease

Abstract

Benign pancreatic hyperenzynemia, also known as Gullo’s syndrome, is a syndrome first described in 1996 by Lucio Gullo which is characterized by an abnormal increase of serum pancreatic enzyme in absence of pancreatic disease. We describe the case of a 62-year-old patient who was found to have significant elevation of amylase levels while she was asymptomatic. Laboratory and imaging tests were performed to determine the etiology, but they gave normal results. The enzyme elevation can be only one enzyme may elevate, although most often all pancreatic enzymes (amilase, isoamilase and/or lipase) are elevated. The etiology is not known. This enzyme elevation is described both in children and adult and sporadically or with a familial pattern. Its knowledge allows us to confirm a benign prognosis about it and reassure and that in the end it will not require aggressive treatments such as surgery or chemotherapy.

Downloads

Download data is not yet available.

References

Gullo L. Chronic nonpathological hyperamylasemia of pancreatic origin. Gastroenterology. 1996;110(6):1905–1908.

Gullo L. Familial pancreatic hyperenzymemia. Páncreas 2000;20:158-160.

Gullo L, Cavicchi L, Tomassetti P, Spagnolo C, Freyrie A, D'Addato M. Effects of ischemia on the human pancreas. Gastroenterology 1996;111:1033-1038.

AEP. Asociación Española de Pediatría. Nov. 2020. Síndrome de Gullo. Redondo Torres Al, León Morillo MR; Quirós Espigares N, Riego Ramos MJ, Cortázar Rocandio G, Rodríguez Barrero S. Servicio de Pediatría. Hospital de Jerez de la Frontera.

Levitt MD, Ellis CJ, Meier PB. Extrapancreatic origin of chronic unexplained hyperamylasemia. N Engl J Med 1980;302: 670-671.

Pérez M, Colina N, Daoud G, Bracho V, Yañez R, Villarreal L. Hiperenzinemia pancreática benigna familiar: Sindrome de Gullo. A proposito de un caso. G E N [Internet]. 2016 [citado el 2 de mayo de 2024];70(1):023–7. Disponible en: https://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0016-35032016000100005

Warshaw AL, Hawboldt MM. Puzzling persistent hyperamylasemia, probably neither pancreatic nor pathologic. Am J Surg 1988;155:453-456.

Cuckow PM, Foo AY, Jamal A, Stringer MD. Familial hyperamylasaemia. Gut 1997;40:689-690.

Gullo L, Ventrucci M, Barakat B, Migliori M, Tomassetti P, Pezzilli R. Effect of secretin on serum pancreatic enymes and on the Wirsung duct in chronic nonpathological pancreatic hyperenzymemia. Pancreatology 2003;3:191-194.

Yang B, Wu W, Su C, Wu J, Yeh C, Lee S. Healthy Chinese with benign pancreatic hyperenzymemia. J Chin Med Assoc 2015;78:623-626.

Cavallini G, Frulloni L, Vaona B, Di Francesco V, Bovo P. Is hyperamylasemia related to dyslipidemia? Gastroenterology 1997;112:1058

Downloads

Published

2024-05-30

Issue

Section

Reportes de Casos - Casos Clínicos

How to Cite

1.
Luraschi Centurión VR, Miranda Vergara RM, Pizurno Marmol OA, Kim R. Benign Pancreatic Hyperenzinemia - Gullo’s Syndrome. UNIDA Sld. [Internet]. 2024 May 30 [cited 2026 Nov. 9];3(2):59-61. Available from: https://revistacientifica.unida.edu.py/publicaciones/index.php/unidasld/article/view/225